.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Identify first generic entrants
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Boehringer Ingelheim
Colorcon
Johnson and Johnson
Argus Health
Daiichi Sankyo
AstraZeneca
Cipla
Moodys
Farmers Insurance

Generated: June 29, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 084423

« Back to Dashboard
NDA 084423 describes PROMAPAR, which is a drug marketed by Parke Davis and is included in five NDAs. Additional details are available on the PROMAPAR profile page.

The generic ingredient in PROMAPAR is chlorpromazine hydrochloride. There are eighteen drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the chlorpromazine hydrochloride profile page.

Summary for NDA: 084423

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Antiemetics
Antipsychotics
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength25MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Healthtrust
Novartis
Accenture
Deloitte
Boehringer Ingelheim
McKinsey
Chubb
Merck
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot